Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
BLPH Bellerophon Therapeutics
0.926
-0.044-4.54%
Symbol
BLPH
Company Name
Bellerophon Therapeutics
Listing Date
02/13/2015
Establishment Date
2009
CEO
Mr. Peter Fernandes
Market
NASDAQ
Employees
20
Securities Type
DR
Fiscal Year Ends
12-31
Address
184 Liberty Corner Road,Suite 302
City
Warren
Province
New Jersey
Country
United States of America
Zip code
07059
Phone
1-908-574-4770
Profile
Bellerophon Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Its product pipeline includes PH-ILD, PH-COPD, INOpulse and PH-Sarc. The company was founded in 2009 and is headquartered in Warren, NJ.
Company Overview
Bellerophon Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of products that address significant unmet medical needs in the treatment of cardiopulmonary diseases. Its product pipeline includes PH-ILD, PH-COPD, INOpulse and PH-Sarc. The company was founded in 2009 and is headquartered in Warren, NJ.
CEO: Mr. Peter Fernandes
Market: NASDAQ
Listing Date: 02/13/2015
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist